Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Subklewe

Showing results (51-60 of 244) with videos related to

Pageof 25
Sort By:
Frontiers in Immunology|April 1, 2021
The PI3K∂-Selective Inhibitor Idelalisib Induces T- and NK-Cell Dysfunction Independently of B-Cell Malignancy-Associated ImmunosuppressionLisa Rohrbacher, Bettina Brauchle, Ana Ogrinc Wagner, et al.
International Journal of Cancer|June 23, 2023
Mechanisms and strategies for safe chimeric antigen receptor T-cell activity controlSophia Stock, Anna-Kristina Klüver, Luisa Fertig, et al.
Neurology|May 14, 2021
Chimeric Antigen Receptor T Cells for Glioblastoma: Current Concepts, Challenges, and Future PerspectivesPhilipp Karschnia, Nico Teske, Niklas Thon, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 30, 2024
Prospects of Synergy: Local Interventions and CAR T Cell Therapy in Solid TumorsAnne Holtermann, Mila Gislon, Martin Angele, et al.
Cancer Immunology, Immunotherapy : CII|September 5, 2014
New generation dendritic cell vaccine for immunotherapy of acute myeloid leukemiaMarion Subklewe, Christiane Geiger, Felix S Lichtenegger, et al.
Plos One|September 11, 2012
CD86 and IL-12p70 are key players for T helper 1 polarization and natural killer cell activation by Toll-like receptor-induced dendritic cellsFelix S Lichtenegger, Katharina Mueller, Bettina Otte, et al.
Nature|May 3, 2013
Structures of the human and Drosophila 80S ribosomeAndreas M Anger, Jean-Paul Armache, Otto Berninghausen, et al.
Journal of Translational Medicine|September 14, 2011
Effects of TLR agonists on maturation and function of 3-day dendritic cells from AML patients in complete remissionBarbara Beck, Daniela Dörfel, Felix S Lichtenegger, et al.
British Journal of Haematology|August 24, 2017
Diagnosis of CLL revisited: increased specificity by a modified five-marker scoring system including CD200Thomas Köhnke, Veronika K Wittmann, Veit L Bücklein, et al.
Blood Advances|June 11, 2024
CAR T-cell toxicities: from bedside to bench, how novel toxicities inform laboratory investigationsFabiana Perna, Samir Parekh, Caroline Diorio, et al.
Pageof 25

Showing results (51-60 of 244) with videos related to

Sort By:
Pageof 25
Frontiers in Immunology|April 1, 2021
The PI3K∂-Selective Inhibitor Idelalisib Induces T- and NK-Cell Dysfunction Independently of B-Cell Malignancy-Associated ImmunosuppressionLisa Rohrbacher, Bettina Brauchle, Ana Ogrinc Wagner, et al.
International Journal of Cancer|June 23, 2023
Mechanisms and strategies for safe chimeric antigen receptor T-cell activity controlSophia Stock, Anna-Kristina Klüver, Luisa Fertig, et al.
Neurology|May 14, 2021
Chimeric Antigen Receptor T Cells for Glioblastoma: Current Concepts, Challenges, and Future PerspectivesPhilipp Karschnia, Nico Teske, Niklas Thon, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 30, 2024
Prospects of Synergy: Local Interventions and CAR T Cell Therapy in Solid TumorsAnne Holtermann, Mila Gislon, Martin Angele, et al.
Cancer Immunology, Immunotherapy : CII|September 5, 2014
New generation dendritic cell vaccine for immunotherapy of acute myeloid leukemiaMarion Subklewe, Christiane Geiger, Felix S Lichtenegger, et al.
Plos One|September 11, 2012
CD86 and IL-12p70 are key players for T helper 1 polarization and natural killer cell activation by Toll-like receptor-induced dendritic cellsFelix S Lichtenegger, Katharina Mueller, Bettina Otte, et al.
Nature|May 3, 2013
Structures of the human and Drosophila 80S ribosomeAndreas M Anger, Jean-Paul Armache, Otto Berninghausen, et al.
Journal of Translational Medicine|September 14, 2011
Effects of TLR agonists on maturation and function of 3-day dendritic cells from AML patients in complete remissionBarbara Beck, Daniela Dörfel, Felix S Lichtenegger, et al.
British Journal of Haematology|August 24, 2017
Diagnosis of CLL revisited: increased specificity by a modified five-marker scoring system including CD200Thomas Köhnke, Veronika K Wittmann, Veit L Bücklein, et al.
Blood Advances|June 11, 2024
CAR T-cell toxicities: from bedside to bench, how novel toxicities inform laboratory investigationsFabiana Perna, Samir Parekh, Caroline Diorio, et al.
Pageof 25